$ZBH (Zimmer Biomet Holdings, Inc.)

$ZBH {{ '2016-04-28T19:58:13+0000' | timeago}} • Webcast

For 1Q16, $ZBH said that adjusted operating profit was $639.1MM or 33.6% of sales, flat vs. 1Q15. Net interest expense and other non-OpEx was $90.7MM. The company's adjusted net earnings were $404.3MM, up 51.5% vs. 1Q15 and adjusted diluted EPS rose 29.9% to $2.00 on 202MM weighted average fully diluted shares outstanding.

$ZBH {{ '2018-01-04T11:55:45+0000' | timeago}} • Announcement

$ZBH received FDA clearance for the Sidus Stem-Free Shoulder system. This is a total shoulder arthroplasty solution for patients with good bone stock that have either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or who had previous surgeries of the shoulder that do not compromise the fixation.

$ZBH {{ '2017-12-26T12:15:53+0000' | timeago}} • Announcement

$ZBH announced positive results from a pilot study demonstrating the safety and efficacy of the nSTRIDE Autologous Protein Solution  Kit for the treatment of knee osteoarthritis, the most common type of arthritis.

$ZBH {{ '2017-12-19T14:31:26+0000' | timeago}} • Announcement

$ZBH appointed Bryan Hanson as President and CEO and a member of the BoD, effective Dec. 19, 2017. Daniel Florin, who has served as Interim CEO since July 11, 2017, will continue in his role as SVP and CFO. Most recently, Hanson served as a $MDT's Executive Committee member and as EVP and President of Medtronic's Minimally Invasive Therapies Group.

$ZBH {{ '2017-12-19T13:16:30+0000' | timeago}} • Announcement

Healthcare company $ZBH has approved a cash dividend of $0.24 per share on its common stock, for the fourth quarter. The dividend is payable on or about January 29, 2018, to stockholders of record on December 29, 2017.

$ZBH {{ '2017-11-01T13:59:52+0000' | timeago}} • Infographic

$ZBH Zimmer Biomet Holdings, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$ZBH {{ '2017-08-08T13:03:16+0000' | timeago}} • Announcement

$ZBH's BoD declared a 3Q17 cash dividend of $0.24 per share. The dividend will be paid on Oct. 27, 2017 to stockholders of record on Sept. 22, 2017.

$ZBH {{ '2017-06-13T11:32:43+0000' | timeago}} • Announcement

Medical device company $ZBH announced that the U.S. FDA has notified the company about the closing out of its warning letter dated June 3, 2015 relating to its Zhejiang, China manufacturing facility. The company added that it will continue to take the necessary actions towards stricter quality control and regulatory compliance going forward.

$ZBH {{ '2017-05-30T21:28:38+0000' | timeago}} • Announcement

$ZBH's Board of Directors approved the payment of a quarterly cash dividend to stockholders for 2Q17. The cash dividend of $0.24 per share will be paid on or about July 28, 2017 to stockholders of record on June 23, 2017.

$ZBH {{ '2017-03-01T15:01:11+0000' | timeago}} • Announcement

$ZBH BoD has approved a quarterly cash dividend for 1Q17. The dividend of $0.24 per share will be paid on or about April 28, 2017 to stockholders of record as on March 31, 2017.

$ZBH {{ '2017-02-02T16:22:10+0000' | timeago}} • Announcement

$ZBH said the U.S. Food and Drug Administration (FDA) approved an expanded 26-week efficacy claim for its single-injection viscosupplement Gel-One Cross-linked Hyaluronate for the treatment of knee pain associated with osteoarthritis.

$ZBH {{ '2017-01-31T17:58:23+0000' | timeago}} • Webcast

During 4Q16, $ZBH continued to make progress towards enhancing and improving its supply chain and manufacturing and quality systems. The company anticipates continued progress towards the replenishment of safety stocks on key cross-sell products throughout 1H17, which will accelerate top line growth during 2H17.

$ZBH {{ '2017-01-31T17:50:45+0000' | timeago}} • Webcast

Healthcare company $ZBH said that it has made strategic investments throughout 2016 to broaden and diversify its musculoskeletal portfolio, including the introduction of more than 50 new clinical technology solutions and services.

$ZBH {{ '2017-01-31T15:39:40+0000' | timeago}} • Announcement

$ZBH expects constant currency revenue for FY17 to increase by approx. 3.7-4.7%. $ZBH expects foreign currency translation to decrease revenues by approx. 1.5%.  Therefore, revenue is expected to be in a range of $7.855-7.930Bil. The Company expects its FY17 diluted EPS to be in a range of $4.37-4.67.

$ZBH {{ '2017-01-31T15:35:34+0000' | timeago}} • Announcement

$ZBH reported lower 4Q16 earnings. Net earnings during the quarter fell 47.5% to $66.6MM from $127MM during 4Q15. Diluted EPS fell 46.8% to $0.33 from $0.62 during 4Q15. Net sales rose 4.1% YoverY to $2Bil. Excluding items, $COH earned $2.14 per share.

$ZBH {{ '2017-01-17T13:23:47+0000' | timeago}} • Announcement

$ZBH implemented a leadership transition that capitalizes on the strength of the its management team. Effective Jan. 23, 2017, Robert Delp will assume the position of President, Americas and join the executive leadership team of the company. Stuart Kleopfer has decided to retire from his position as President, Americas.

$ZBH {{ '2017-01-12T20:36:06+0000' | timeago}} • Announcement

$ZBH concluded agreements with the U.S. Department of Justice and the U.S. Securities and Exchange Commission to resolve the U.S. Foreign Corrupt Practices Act (FCPA) matters involving Biomet as well as in relation to former deferred prosecution agreement and consent to final judgment that Biomet entered into with DOJ and SEC, on March 26, 2012.

$ZBH {{ '2017-01-10T13:09:46+0000' | timeago}} • Announcement

$ZBH expects 2016 net sales of $7.684Bil, up 28.1% from last year. On an adjusted constant currency basis, $ZBH sees revenue to increase by 3.4%. Excluding contribution from the LDR Holding transaction, revenue rose by 2.3% on an adjusted constant currency basis. $ZBH now sees adjusted EPS to be towards upper end of prior estimate of $7.90-7.95.

$ZBH {{ '2017-01-10T13:06:47+0000' | timeago}} • Announcement

$ZBH expects 4Q16 net sales of about $2.013Bil, an increase of 4.1% over last year. On adjusted constant currency basis, revenue increased by 4.4%. Excluding the contribution from the LDR transaction and adjusting for one less billing day in the quarter, $ZBH estimates that revenues increased 3.5% over 4Q15.

$ZBH {{ '2016-12-19T12:45:06+0000' | timeago}} • Announcement

$ZBH BoD approved a quarterly cash dividend for 4Q16 of $0.24 per share, payable on or about Jan. 27, 2017 to stockholders of record as of the close of business on Dec. 30, 2016.

$ZBH {{ '2016-12-06T20:15:45+0000' | timeago}} • Announcement

$ZBH priced an offering of EUR 500MM of its 1.414% senior unsecured notes due 2022 and EUR 500MM of 2.425% senior unsecured notes due 2026. The closing is expected to occur on Dec. 13, 2016. The notes will pay interest on an annual basis. The joint book-running managers for the offering are BNP Paribas, HSBC Bank plc and RBC Europe Limited.

Recent Transcripts

INFO (IHS Markit Ltd.)
Tuesday, January 16 2018 - 1:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, December 7 2017 - 10:00pm
HOME (At Home Group Inc.)
Wednesday, November 29 2017 - 9:30pm
MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
VVV (Valvoline Inc.)
Thursday, November 9 2017 - 2:00pm
ATHX (Athersys, Inc.)
Wednesday, November 8 2017 - 9:30pm
VCEL (Vericel Corporation)
Tuesday, November 7 2017 - 1:00pm
BHF (Brighthouse Financial, Inc.)
Thursday, November 2 2017 - 4:00pm
DWDP (DowDuPont Inc.)
Thursday, November 2 2017 - 12:00pm
WMGI (Wright Medical Group N.V.)
Wednesday, November 1 2017 - 8:30pm
STE (Steris Plc)
Wednesday, November 1 2017 - 2:00pm
ZBH (Zimmer Biomet Holdings, Inc.)
Wednesday, November 1 2017 - 12:00pm
BIVV (Bioverativ Inc.)
Friday, October 27 2017 - 12:00pm
ITGR (Integer Holdings Corporation)
Thursday, October 26 2017 - 9:00pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
NUVA (NuVasive, Inc.)
Tuesday, October 24 2017 - 8:30pm
ISRG (Intuitive Surgical, Inc.)
Thursday, October 19 2017 - 8:30pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, September 7 2017 - 9:00pm
HOME (At Home Group Inc.)
Tuesday, September 5 2017 - 8:30pm

AlphaGraphics you may like